Medmox CV

Medmox CV is a combination antibiotic containing amoxicillin, a semisynthetic beta-lactam antibiotic, and clavulanic acid, a beta-lactamase inhibitor. Developed and marketed by Med Manor Organics, it is widely used to treat various bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and middle ear or sinus infections. Amoxicillin works by binding to and inhibiting penicillin-binding proteins (PBPs), which are essential for bacterial cell wall synthesis, leading to cell lysis and death. Clavulanic acid acts as a suicide inhibitor of beta-lactamase enzymes, preventing them from degrading amoxicillin and thereby overcoming bacterial resistance.

Brand names

Medmox CVMedmox-CV

Other names

amoxicillin + clavulanic acidamoxicillin/clavulanic acidamoxycillin + clavulanic acidco-amoxiclav